Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist PegvisomantPeter Trainer, John A. Scarlett, William M Drake et al.|New England Journal of Medicine|2000Cited by 874
Guidelines for Acromegaly Management: An UpdateШломо Мелмед, Annamaria Colao, Ariel L. Barkan et al.|The Journal of Clinical Endocrinology & Metabolism|2009Cited by 763
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonistAart Jan van der Lely, Michael O. Thorner, R. Kent Hutson et al.|The Lancet|2001Cited by 643
Evaluation of Acromegaly by Radioimmunoassay of Somatomedin-CDavid R. Clemmons, L E Underwood, Judson J. Van Wyk et al.|New England Journal of Medicine|1979Cited by 367
Reduction of Plasma Immunoreactive Somatomedin C during Fasting in Humans*David R. Clemmons, Judson J. Van Wyk, Anne Klibanski et al.|The Journal of Clinical Endocrinology & Metabolism|1981Cited by 366